Found: 62
Select item for more details and to access through your institution.
Stem Cell Transplant for First Relapse.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1818
- By:
- Publication type:
- Article
New Questions About Transplantation in Multiple Myeloma.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 10, p. 1230
- By:
- Publication type:
- Article
Multiple Myeloma: An Old Disease with New Hope for the Future.
- Published in:
- CA: A Cancer Journal for Clinicians, 2001, v. 51, n. 5, p. 273, doi. 10.3322/canjclin.51.5.273
- By:
- Publication type:
- Article
Toxoplasma pneumonia: Cytologic diagnosis by bronchoalveolar lavage.
- Published in:
- Diagnostic Cytopathology, 1994, v. 11, n. 1, p. 52, doi. 10.1002/dc.2840110112
- By:
- Publication type:
- Article
The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance.
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, n. 9, p. 1440, doi. 10.1093/ndt/gfy259
- By:
- Publication type:
- Article
New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1652, doi. 10.3390/jcm9061652
- By:
- Publication type:
- Article
New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1828, doi. 10.3390/jcm8111828
- By:
- Publication type:
- Article
Immune tolerance with combined allogeneic haplo‐identical haematopoietic stem cell transplant and renal transplant.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 4, p. 779, doi. 10.1111/bjh.17540
- By:
- Publication type:
- Article
Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 2, p. 231, doi. 10.1111/bjh.15394
- By:
- Publication type:
- Article
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 3, p. 440, doi. 10.1111/bjh.14429
- By:
- Publication type:
- Article
Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 1, p. 52, doi. 10.1111/bjh.13517
- By:
- Publication type:
- Article
A Novel Multiparametric Approach for Analysis of Cytoplasmic Immunoglobulin Light Chains by Flow Cytometry.
- Published in:
- Modern Pathology, 2001, v. 14, n. 10, p. 1015, doi. 10.1038/modpathol.3880427
- By:
- Publication type:
- Article
Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high‐risk multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. E430, doi. 10.1002/ajh.26333
- By:
- Publication type:
- Article
A phase 1b study of once‐weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 226, doi. 10.1002/ajh.26041
- By:
- Publication type:
- Article
Hospital facility characteristics and socioeconomic factors on outcomes and treatment in patients with multiple myeloma: National Cancer Database analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1443, doi. 10.1007/s00277-023-05194-6
- By:
- Publication type:
- Article
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Recent Advancements and Future Directions in Frontline Treatment of Multiple Myeloma.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 7, p. 438
- By:
- Publication type:
- Article
Principles of prevention and management of adverse events of immunomodulatory drugs in the treatment of multiple myeloma.
- Published in:
- Nowotwory, 2022, v. 72, n. 4, p. 231, doi. 10.5603/NJO.a2022.0031
- By:
- Publication type:
- Article
Effect of a 6-Week Cycle of Nordic Walking Training on Vitamin 25(OH)D 3, Calcium-Phosphate Metabolism and Muscle Damage in Multiple Myeloma Patients–Randomized Controlled Trial.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 21, p. 6534, doi. 10.3390/jcm11216534
- By:
- Publication type:
- Article
Blocking MET receptor signaling in multiple myeloma cells in vitro and in vivo.
- Published in:
- Advances in Clinical & Experimental Medicine, 2018, v. 27, n. 2, p. 153, doi. 10.17219/acem/68271
- By:
- Publication type:
- Article
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1592, doi. 10.3390/cancers16081592
- By:
- Publication type:
- Article
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4359, doi. 10.3390/cancers15174359
- By:
- Publication type:
- Article
Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4666, doi. 10.3390/cancers13184666
- By:
- Publication type:
- Article
Association Between Renal Cell Carcinoma and Plasma Cell Dyscrasias: A Case Series of Six Patients.
- Published in:
- Clinical Lymphoma & Myeloma, 2008, v. 8, n. 3, p. 188
- By:
- Publication type:
- Article
Liver Involvement in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 8, p. 538
- By:
- Publication type:
- Article
Bortezomib-Induced Tumor Lysis Syndrome in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 3, p. 233
- By:
- Publication type:
- Article
Engraftment Syndrome After Hematopoietic Stem Cell Transplantation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 2, p. 151
- By:
- Publication type:
- Article
Subepithelial Corneal Immunoglobulin Deposition as a Manifestation of Multiple Myeloma: A Case Report and Literature Review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2014, v. 14, n. 1, p. e39, doi. 10.1016/j.clml.2013.09.012
- By:
- Publication type:
- Article
Phase II Trial of Syncopated Thalidomide, Lenalidomide, and Weekly Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 3, p. 186, doi. 10.1016/j.clml.2012.01.004
- By:
- Publication type:
- Article
Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 6, p. 458, doi. 10.3816/CLML.2010.n.078
- By:
- Publication type:
- Article
Intracranial Multifocal Dural Involvement in Multiple Myeloma: Case Report and Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. 220, doi. 10.3816/CLML.2010.n.035
- By:
- Publication type:
- Article
Vorinostat Plus Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma: A Case Series Illustrating Utility in Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 2, p. 149, doi. 10.3816/CLML.2010.n.022
- By:
- Publication type:
- Article
Management of renal dysfunction in multiple myeloma.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Initial immunoglobulin M flare after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemiaThe current study was conducted by the Eastern Cooperative Oncology Group (Dr. Robert L. Comis, Chairman).: An Eastern Cooperative Oncology Group Study
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 11, p. 2593, doi. 10.1002/cncr.20658
- By:
- Publication type:
- Article
Effect of low-dose granulocyte-macrophage colony-stimulating factor (LD-GM-CSF) on platelet transfusion-dependent thrombocytopenia.
- Published in:
- American Journal of Hematology, 1994, v. 47, n. 3, p. 203, doi. 10.1002/ajh.2830470311
- By:
- Publication type:
- Article
The Current State of Knowledge About Evolution of Multiple Myeloma to Plasma Cell Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. 188, doi. 10.1016/j.clml.2022.12.002
- By:
- Publication type:
- Article
Prevalence and Survival Impact of Self-Reported Symptom and Psychological Distress Among Patients With Multiple Myeloma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple Myeloma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Multiple Myeloma in Pregnancy--A Review of the Literature and a Case Series.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Supportive care in multiple myeloma.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. 4, p. 227, doi. 10.5603/AHP.a2022.0031
- By:
- Publication type:
- Article
The importance of cytogenetic and molecular aberrations in multiple myeloma.
- Published in:
- Acta Haematologica Polonica, 2021, v. 52, n. 4, p. 361, doi. 10.5603/AHP.2021.0069
- By:
- Publication type:
- Article
The importance of cytogenetic and molecular aberrations in multiple myeloma.
- Published in:
- Acta Haematologica Polonica, 2021, v. 52, n. 4, p. 361, doi. 10.5603/AHP.2021.0069
- By:
- Publication type:
- Article
I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00733-2
- By:
- Publication type:
- Article
Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case series.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case‐control study.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. E238, doi. 10.1002/ajh.25209
- By:
- Publication type:
- Article
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 575, doi. 10.1002/ajh.24351
- By:
- Publication type:
- Article
Therapy-related leukemia in patients with human immunodeficiency virus infection after treatment for non-Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 12, p. 937, doi. 10.1002/ajh.21290
- By:
- Publication type:
- Article
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma.
- Published in:
- British Journal of Haematology, 2010, v. 148, n. 4, p. 562, doi. 10.1111/j.1365-2141.2009.07981.x
- By:
- Publication type:
- Article
Active and suppressor T cells: diminution in a patient with dyskeratosis congenita and in first-degree relatives.
- Published in:
- 1979
- By:
- Publication type:
- journal article